Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis - Wikidata - awgldk - TriplyDB

Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis

Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis

http://www.wikidata.org/entity/Q34955313

about

Replication Study: Discovery and preclinical validation of drug indications using compendia of public gene expression data Discovery, semisynthesis, biological activities, and metabolism of ocotillol-type saponins.Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complex Semi-synthetic ocotillol analogues as selective ABCB1-mediated drug resistance reversal agents.Angiotensin II protects cortical neurons against oxygen-glucose deprivation-induced injury in vitro.Lx2-32c, a novel semi-synthetic taxane, exerts antitumor activity against prostate cancer cells in vitro and in vivo.Inorganic Phosphate Prevents Erk1/2 and Stat3 Activation and Improves Sensitivity to Doxorubicin of MDA-MB-231 Breast Cancer Cells.

P2860

Q28559693-2437B682-CD64-4864-90E3-28C19DA8736F Q33849986-959B7259-C455-4143-BA12-69312E5704AF Q35824678-6E0745AA-1C68-411F-AA0A-F3ACE29577D1 Q36414444-8152B1B1-121B-4DE5-9A04-0FDF10A6B170 Q37565012-D88ACAF1-46AE-4642-B09C-1F1576D22553 Q37587330-C938C701-6AD0-461F-9D91-0C28C81A699F Q38837835-FCF9595F-78AD-4FB7-A607-0C52037DBF50

P2860

Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis

http://www.wikidata.org/entity/Q34955313

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis

@ast

Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis

@en

Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis

@nl

type

label

Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis

@ast

Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis

@en

Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis

@nl

prefLabel

Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis

@ast

Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis

@en

Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis

@nl

P1433

Q34955313-E7412AA8-3693-4B60-81F0-84A49B086BF9

P1476

Q34955313-2F9E4F0F-993E-4BE3-9EE0-E1420191E417

P2093

Q34955313-2AAD483D-C094-464A-B614-48077997DB37

Q34955313-3728CBAA-52A2-49B9-8B00-FF7507C0B45D

Q34955313-43C728DF-91F7-4ACD-85FB-8C018BD939DD

Q34955313-522C2965-61F9-4D9D-9F9B-9E3D06A6819B

Q34955313-52314AFC-8461-4C1E-B72E-8E01A48382A9

Q34955313-5AA92154-7E89-4B09-820F-99197EE330D3

Q34955313-91DBF6CE-E7F1-4611-B628-31BB4D286F4B

Q34955313-BFE28340-43AA-4D83-8D35-147C53986147

Q34955313-C5363D40-15A7-4298-88C1-05B343E6A317

Q34955313-D73139B5-364A-490E-B919-2DBA50882408

P2860

Q34955313-04C2F751-03CC-4AA8-90CF-A13F8374785A

Q34955313-074840A0-0E42-42D2-B9E8-B1D963FA36BF

Q34955313-0DE23925-E7DC-4237-A646-A652CD2FDF68

Q34955313-1FD2C2FA-4228-4A74-B010-374023498488

Q34955313-2103730E-6769-4C06-A676-5CF99D4A57F7

Q34955313-2E5E868C-F8BA-42C4-AB6D-6E5FF2017849

Q34955313-38E8E0CE-7F78-4730-AE45-45B18601DC49

Q34955313-3DB62554-E366-47CC-A2F3-651B194A100E

Q34955313-44EDB0E1-E09D-44E2-9CE3-5BF5F909EEA1

Q34955313-4609CF25-E2A7-4F42-A541-1D67892DBB2B

P304

Q34955313-257FA470-980D-4B2F-9DE1-78E7ACB58F8C

P31

Q34955313-57FF3C3E-FA7A-4B8D-BAC8-BF91297AD4AF

P356

Q34955313-D61CC477-F1D9-47C0-BAB3-E2CEB66B0837

P478

Q34955313-6D8DBF3C-92DF-4421-AD02-A8D207C276B1

P577

Q34955313-5119B526-D9C6-4E79-B4E1-DF2653C26EAE

P5875

Q34955313-9030AFC8-4B3F-45A8-B449-4CA507FB1429

P698

Q34955313-9721E414-EC07-4F92-AC29-5A7FD59E5116

P932

Q34955313-3E4D1B0F-63BA-42C8-A464-559A5D4B1FD2

P356

P1433

Evidence-based Complementary and Alternative Medicine

P1476

Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis

@en

P2093

Fangxi Zhang

http://www.w3.org/2001/XMLSchema#string

Fenghua Fu

http://www.w3.org/2001/XMLSchema#string

Guangying Du

http://www.w3.org/2001/XMLSchema#string

Hongbo Wang

http://www.w3.org/2001/XMLSchema#string

Jianqiao Zhang

http://www.w3.org/2001/XMLSchema#string

Jing Bai

http://www.w3.org/2001/XMLSchema#string

Jingwei Tian

http://www.w3.org/2001/XMLSchema#string

Liang Kong

http://www.w3.org/2001/XMLSchema#string

Lixia Zhang

http://www.w3.org/2001/XMLSchema#string

Pengfei Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Ginsenosides from American ginseng: chemical and pharmacological diversity

The first 30 years of p53: growing ever more complex

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

The p53 pathway: positive and negative feedback loops

Features of apoptotic cells measured by flow cytometry.

Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.

Curcumin enhanced adriamycin-induced human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagy.

Anticancer drug discovery and development throughout the world.

Awakening guardian angels: drugging the p53 pathway.

P304

468537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/468537

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255976974

http://www.w3.org/2001/XMLSchema#string

P698

23956772

http://www.w3.org/2001/XMLSchema#string

P932

3727205

http://www.w3.org/2001/XMLSchema#string